0001209191-22-039240.txt : 20220624
0001209191-22-039240.hdr.sgml : 20220624
20220624162821
ACCESSION NUMBER: 0001209191-22-039240
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220622
FILED AS OF DATE: 20220624
DATE AS OF CHANGE: 20220624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHAFFER CHRISTY L
CENTRAL INDEX KEY: 0001145929
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 221040452
MAIL ADDRESS:
STREET 1: INSPIRE PHARMACEUTICALS, INC.,
STREET 2: 4222 EMPEROR BLVD., STE. 470
CITY: DURHAM
STATE: NC
ZIP: 27703-8466
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clearside Biomedical, Inc.
CENTRAL INDEX KEY: 0001539029
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452437375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-270-3631
MAIL ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-22
0
0001539029
Clearside Biomedical, Inc.
CLSD
0001145929
SHAFFER CHRISTY L
C/O CLEARSIDE BIOMEDICAL, INC.
900 NORTH POINT PARKWAY, SUITE 200
ALPHARETTA
GA
30005
1
0
0
0
Stock Option (right to buy)
1.62
2022-06-22
4
A
0
30000
0.00
A
2032-06-21
Common Stock
30000
30000
D
The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2023.
/s/ Mark Ballantyne, Attorney-in-Fact
2022-06-24